These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26042736)

  • 41. Public-private partnerships to revitalize psychiatric drug discovery.
    Brady LS; Potter WZ
    Expert Opin Drug Discov; 2014 Jan; 9(1):1-8. PubMed ID: 24308355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Four disruptive strategies for removing drug discovery bottlenecks.
    Ekins S; Waller CL; Bradley MP; Clark AM; Williams AJ
    Drug Discov Today; 2013 Mar; 18(5-6):265-71. PubMed ID: 23098820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patent-free pact pushes the boundaries of precompetitive research.
    Dolgin E
    Nat Med; 2014 Jun; 20(6):564-5. PubMed ID: 24901552
    [No Abstract]   [Full Text] [Related]  

  • 44. Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need.
    Hirsch G; Trusheim M; Cobbs E; Bala M; Garner S; Hartman D; Isaacs K; Lumpkin M; Lim R; Oye K; Pezalla E; Saltonstall P; Selker H
    Clin Pharmacol Ther; 2016 Dec; 100(6):685-698. PubMed ID: 27626610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Open for collaboration: an academic platform for drug discovery and development at SciLifeLab.
    Arvidsson PI; Sandberg K; Forsberg-Nilsson K
    Drug Discov Today; 2016 Oct; 21(10):1690-1698. PubMed ID: 27373760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Public-Private Partnerships: Compound and Data Sharing in Drug Discovery and Development.
    Davis AM; Engkvist O; Fairclough RJ; Feierberg I; Freeman A; Iyer P
    SLAS Discov; 2021 Jun; 26(5):604-619. PubMed ID: 33586501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Who, What, and Why of Drug Discovery and Development.
    Hogan G; Tangney M
    Trends Pharmacol Sci; 2018 Oct; 39(10):848-852. PubMed ID: 30196936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
    Perakslis ED; Van Dam J; Szalma S
    Clin Pharmacol Ther; 2010 May; 87(5):614-6. PubMed ID: 20376001
    [No Abstract]   [Full Text] [Related]  

  • 49. Proceedings of the 2013 CINP summit: innovative partnerships to accelerate CNS drug discovery for improved patient care.
    Phillips AG; Hongaard-Andersen P; Moscicki RA; Sahakian B; Quirion R; Krishnan KR; Race T
    Int J Neuropsychopharmacol; 2014 Dec; 18(3):. PubMed ID: 25542690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measuring the effectiveness and impact of an open innovation platform.
    Carroll GP; Srivastava S; Volini AS; Piñeiro-Núñez MM; Vetman T
    Drug Discov Today; 2017 May; 22(5):776-785. PubMed ID: 28137644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Technology transfer: seeking a more efficient way.
    Wilkinson JM
    Med Device Technol; 2006; 17(9):36, 38-9. PubMed ID: 17240686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Open access chemical and clinical probes to support drug discovery.
    Edwards AM; Bountra C; Kerr DJ; Willson TM
    Nat Chem Biol; 2009 Jul; 5(7):436-40. PubMed ID: 19536100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accelerating Medicines Partnership: Alzheimer's Disease (AMP-AD) Knowledge Portal Aids Alzheimer's Drug Discovery through Open Data Sharing.
    Hodes RJ; Buckholtz N
    Expert Opin Ther Targets; 2016; 20(4):389-91. PubMed ID: 26853544
    [No Abstract]   [Full Text] [Related]  

  • 54. [Challenges and strategies of drug innovation].
    Guo ZR; Zhao HY
    Yao Xue Xue Bao; 2013 Jul; 48(7):1031-40. PubMed ID: 24133969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Success factors for open access.
    Till JE
    J Med Internet Res; 2003; 5(1):e1. PubMed ID: 12746206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Industry is more alarmed about reproducibility than academia.
    Bespalov A; Barnett AG; Begley CG
    Nature; 2018 Nov; 563(7733):626. PubMed ID: 30487623
    [No Abstract]   [Full Text] [Related]  

  • 57. The successes and challenges of open-source biopharmaceutical innovation.
    Allarakhia M
    Expert Opin Drug Discov; 2014 May; 9(5):459-65. PubMed ID: 24702304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Translational research: moving discovery to practice.
    Zerhouni EA
    Clin Pharmacol Ther; 2007 Jan; 81(1):126-8. PubMed ID: 17186011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of public-private partnerships in addressing the biomedical innovation challenge.
    Said M; Zerhouni E
    Nat Rev Drug Discov; 2014 Nov; 13(11):789-90. PubMed ID: 25359362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Academia-pharma partnerships for novel drug discovery: essential or nice to have?
    Palmer M; Chaguturu R
    Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.